跳至主要内容
临床试验/NCT00156039
NCT00156039已完成4 期

A Randomized Trial of Follow-up Strategies in Breast Cancer

Ontario Clinical Oncology Group (OCOG)5 个研究点 分布在 1 个国家目标入组 968 人开始时间: 1997年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
968
试验地点
5
主要终点
Rate of Karnofsky performance status < 70

研究概览

简要总结

The purpose of this study is to determine whether family physician 'routine follow-up care' of women with breast cancer in remission is an acceptable alternative to the existing system of specialist follow-up. Primary outcome measure are event rates of oncological catastrophes and quality of life.

详细描述

see above

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Women with breast cancer on well follow-up at regional cancer centres in Ontario and Manitoba
  • •Diagnosed at least 12 months previously (range 9-15 months)
  • •Without evidence of active disease (i.e., stages IIIB and IV excluded)
  • •Free from any primary treatment complications

排除标准

  • •Primary treatment at least 3 months previously, except for continued use of tamoxifen
  • •Still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
  • •Unable to identify an acceptable family physician to provide follow-up
  • •Language or literacy skills inconsistent with completing questionnaires
  • •Unable to comply with study protocol including completion of questionnaires
  • •Previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
  • •Actively followed at a cancer centre for another primary cancer

结局指标

主要结局

Rate of Karnofsky performance status < 70

时间窗: Up to 5 yrs after randomization

Rate of clinically catastrophic events

时间窗: Up to 5 yrs after randomization

Psychosocial well being of patients in remission

时间窗: Up to 5 yrs after randomization

次要结局

  • Economic evaluation(Up to 5 yrs after randomization)
  • Survival(Up to 5 yrs after randomization)
  • Health Related Quality of Life after recurrence(Up to 5 yrs after randomization)

研究者

发起方
Ontario Clinical Oncology Group (OCOG)
申办方类型
Other

研究点 (5)

Loading locations...

相似试验